FDA launches review of COX-Two inhibitors, warns caution on all ...
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
633529
Doctors who led three studies showing prescription painkillers called COX-2 inhibitors raise the risk of heart attacks and stroke said on Tuesday the whole class of drugs was in danger of being pulled from the market.
415629
20/12/2004 - The safety of cox-2 inhibitors was plunged into further uncertainty after Pfizer released details of trials that found an increased risk of heart problems with patients taking its painkiller Celebrex.
585616
U.S. health officials urged doctors  on Friday to consider prescribing alternatives to Pfizer Inc.'s   arthritis drug Celebrex while regulators weigh new data on  heart risks.
639005
The White House says the Food and Drug administration is doing a &quot;spectacular&quot; job. Really? The FDA didn&#39;t respond to warning signs that block-buster painkillers like Celebrex and Vioxx increased the risk of heart attacks.
665220
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis drug pulled from the market last week after a study suggested it doubled the risk of heart attacks and strokes.
14152
Drugs in the same category as Merck &amp; Co. Inc.&#39;s withdrawn Vioxx painkiller will get close scrutiny to see if they can also cause heart attacks, US Food and Drug Administration officials said on Thursday.
137354
The Food and Drug Administration announced Friday its intentions to conduct a major evaluation of its approach in dealing with safety concerns involving drugs, primarily those that are already marketed.
15642
NEW YORK, December 21  - The US Food and Drug Administration (FDA) warned today against the long-term usage of another arthritis drug, naproxen, after studies revealed increased risks of cardiovascular events.
189407
U.S. regulators have "serious concerns"  about painkilling drugs in the class known as COX-2 inhibitors  and are due to issue a new ruling on them within days, the  Financial Times reported on its Web site on Sunday.
376359
DECEMBER 24, 2004 -- The FDA&#39;s recent warnings about drugs such as Vioxx, Celebrex and Aleve have left some people on edge, but one area doctor says one of those drugs is still safe.
178529
Benefits must exceed risks if COX-2 inhibitors are prescribed; patients need to stick to labeled NSAID dosages, limit use to 10 days.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
105508
Two leading heart experts called for urgent investigations on Wednesday into whether all painkilling drugs known as COX-2 inhibitors may raise the risk of heart attack in some people.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
48973
The spotlight is likely to be on Pfizer on Wednesday when federal drug regulators begin hearings on cox-2 drugs, the medicines that include Celebrex and Bextra.